Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR

Abstract

The rapid advancement of a series of noncovalent inhibitors of T790M mutants of EGFR is discussed. The optimization of pyridone 1, a nonselective high-throughput screening hit, to potent molecules with high levels of selectivity over wtEGFR and the broader kinome is described herein.